Stockreport

Earnings Release: Here's Why Analysts Cut Their Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Price Target To US$8.00 [Yahoo! Finance]

Marinus Pharmaceuticals, Inc.  (MRNS) 
Last marinus pharmaceuticals, inc. earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.marinuspharma.com/investor-relations
PDF The numbers were weak, with revenues of US$7.7m coming in 16% short of analyst estimates. Statutory losses were US$0.68 per share, 3.0% larger than what the analysts exp [Read more]